ATIC
Gene Information
- Official Symbol: ATIC
- Official Name: 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase/IMP cyclohydrolase
- Aliases and Previous Symbols: N/A
- Entrez ID: 471
- UniProt: P31939
- Interactions: BioGRID
- PubMed articles: Open PubMed
- OMIM: Open OMIM
Function Summary
- Entrez Summary: This gene encodes a bifunctional protein that catalyzes the last two steps of the de novo purine biosynthetic pathway. The N-terminal domain has phosphoribosylaminoimidazolecarboxamide formyltransferase activity, and the C-terminal domain has IMP cyclohydrolase activity. A mutation in this gene results in AICA-ribosiduria. [provided by RefSeq, Sep 2009].
- UniProt Summary: Bifunctional enzyme that catalyzes 2 steps in purine biosynthesis. {ECO:0000269|PubMed:14966129}.
Pfam Domains GO Terms
Pfam Domains
| MGS |
| AICARFT IMPCHas |
GO Terms
| IMP cyclohydrolase activity |
| phosphoribosylaminoimidazolecarboxamide formyltransferase activity |
| dihydrofolate metabolic process |
| de novo IMP biosynthetic process |
| brainstem development |
| tetrahydrofolate biosynthetic process |
| IMP biosynthetic process |
| folic acid-containing compound biosynthetic process |
| IMP metabolic process |
| pteridine-containing compound biosynthetic process |
| purine nucleoside monophosphate biosynthetic process |
| tetrahydrofolate metabolic process |
| purine ribonucleoside monophosphate biosynthetic process |
| response to interleukin-7 |
| cellular response to interleukin-7 |
| folic acid-containing compound metabolic process |
| ribonucleoside monophosphate biosynthetic process |
| pteridine-containing compound metabolic process |
| purine ribonucleoside monophosphate metabolic process |
| purine nucleoside monophosphate metabolic process |
| nucleoside monophosphate biosynthetic process |
| cellular modified amino acid biosynthetic process |
| ribonucleoside monophosphate metabolic process |
| nucleoside monophosphate metabolic process |
| animal organ regeneration |
| dicarboxylic acid metabolic process |
| cerebellum development |
| nucleoside metabolic process |
| metencephalon development |
| cerebral cortex development |
| glycosyl compound metabolic process |
| coenzyme biosynthetic process |
| purine ribonucleotide biosynthetic process |
| hindbrain development |
| purine nucleotide biosynthetic process |
| regeneration |
| ribonucleotide biosynthetic process |
| ribose phosphate biosynthetic process |
| purine-containing compound biosynthetic process |
| pallium development |
| cellular modified amino acid metabolic process |
| cofactor biosynthetic process |
| nucleotide biosynthetic process |
| nucleoside phosphate biosynthetic process |
| coenzyme metabolic process |
| telencephalon development |
| carboxylic acid biosynthetic process |
| organic acid biosynthetic process |
| cadherin binding |
| purine ribonucleotide metabolic process |
| ribonucleotide metabolic process |
| purine nucleotide metabolic process |
| ribose phosphate metabolic process |
| purine-containing compound metabolic process |
| forebrain development |
| cofactor metabolic process |
| nucleotide metabolic process |
| nucleoside phosphate metabolic process |
| amide biosynthetic process |
| response to inorganic substance |
| organophosphate biosynthetic process |
| nucleobase-containing small molecule metabolic process |
| small molecule biosynthetic process |
| carbohydrate derivative biosynthetic process |
| brain development |
| head development |
| cellular amide metabolic process |
| protein homodimerization activity |
| organophosphate metabolic process |
| carboxylic acid metabolic process |
| central nervous system development |
| oxoacid metabolic process |
| cellular response to cytokine stimulus |
| organic acid metabolic process |
| carbohydrate derivative metabolic process |
| nucleobase-containing compound biosynthetic process |
| response to cytokine |
| heterocycle biosynthetic process |
| aromatic compound biosynthetic process |
| organic cyclic compound biosynthetic process |
| organonitrogen compound biosynthetic process |
| cellular nitrogen compound biosynthetic process |
| small molecule metabolic process |
| membrane |
CRISPR Data
Compound Hit Most Correlated Genes in Chemogenomics Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Compound Hit
Most Correlated Genes in Chemogenomics
| Gene | Correlation |
|---|---|
| THG1L | 0.634 |
| VEZT | 0.611 |
| ATXN10 | 0.572 |
| AASDHPPT | 0.567 |
| SLC25A26 | 0.564 |
| FH | 0.552 |
| SLC25A19 | 0.548 |
| RPIA | 0.546 |
| GEMIN6 | 0.538 |
| URM1 | 0.535 |
| TRIAP1 | 0.532 |
| GEMIN8 | 0.53 |
| DPAGT1 | 0.524 |
| PPCS | 0.52 |
| ELP3 | 0.52 |
| BCS1L | 0.516 |
| SRP14 | 0.514 |
| TPK1 | 0.509 |
| PGM3 | 0.509 |
| ELP2 | 0.506 |
| C15orf41 | 0.505 |
| DR1 | 0.503 |
| ALG1 | 0.503 |
| DOLK | 0.5 |
| RPE | 0.498 |
| RFK | 0.495 |
| SSB | 0.494 |
| UAP1 | 0.493 |
| ADSL | 0.492 |
| PMM2 | 0.487 |
| DHRSX | 0.486 |
| DARS2 | 0.486 |
| TRMT61A | 0.486 |
| TKT | 0.483 |
| HSD17B10 | 0.477 |
| LSM10 | 0.475 |
| MTHFD1 | 0.473 |
| MRPS14 | 0.472 |
| CHCHD4 | 0.472 |
| DOHH | 0.471 |
| RFT1 | 0.47 |
| MOCS3 | 0.469 |
| KDSR | 0.467 |
| DNLZ | 0.467 |
| UBA3 | 0.465 |
| GMPPB | 0.462 |
| WDR92 | 0.461 |
| TEN1 | 0.458 |
| RABGGTB | 0.458 |
| TTC4 | 0.455 |
| PYROXD1 | 0.454 |
| KIAA0391 | 0.453 |
| MRPS34 | 0.451 |
| SRD5A3 | 0.451 |
| DAP3 | 0.447 |
| ZRSR2 | 0.447 |
| DDX1 | 0.446 |
| MRPS2 | 0.445 |
| CTU1 | 0.443 |
| MRPS16 | 0.443 |
| ROMO1 | 0.44 |
| ELP6 | 0.44 |
| ZCRB1 | 0.439 |
| SCO2 | 0.438 |
| MRPL21 | 0.436 |
| NFU1 | 0.436 |
| TSEN54 | 0.433 |
| RPP21 | 0.433 |
| UQCRC2 | 0.43 |
| RTCB | 0.43 |
| RBFA | 0.43 |
| TUBD1 | 0.429 |
| TAMM41 | 0.429 |
| GFPT1 | 0.427 |
| GTF3C3 | 0.427 |
| SUPV3L1 | 0.425 |
| N6AMT1 | 0.422 |
| MRPS6 | 0.421 |
| YARS2 | 0.42 |
| SARS2 | 0.42 |
| MRPL27 | 0.42 |
| RPTOR | 0.418 |
| TRMT5 | 0.418 |
| WDR59 | 0.417 |
| HCCS | 0.417 |
| ELAC2 | 0.416 |
| NAE1 | 0.416 |
| TMEM208 | 0.416 |
| KCTD5 | 0.413 |
| GEMIN7 | 0.413 |
| UQCR10 | 0.412 |
| PPCDC | 0.412 |
| GFM1 | 0.412 |
| MRPS26 | 0.412 |
| PPP6C | 0.411 |
| COX16 | 0.41 |
| DHPS | 0.41 |
| MIS18A | 0.41 |
| UHRF1 | 0.41 |
| CEP57 | 0.409 |
| BAK1 | 0.407 |
| ORAOV1 | 0.407 |
| MRPS21 | 0.406 |
| RAD1 | 0.404 |
| TUFM | 0.403 |
| PPA1 | 0.401 |
| C14orf80 | 0.401 |
| DDX39A | 0.4 |
Tissues where Essential in the Avana Dataset (DepMap 20Q1)
Global Fraction of Cell Lines Where Essential: 43/739
| Tissue | Fraction Of Cell Lines Where Essential |
|---|---|
| 1290807.0 | 0/1 |
| 909776.0 | 0/1 |
| bile duct | 2/28 |
| blood | 2/28 |
| bone | 2/26 |
| breast | 5/33 |
| central nervous system | 1/56 |
| cervix | 0/4 |
| colorectal | 0/17 |
| esophagus | 0/13 |
| fibroblast | 0/1 |
| gastric | 0/16 |
| kidney | 1/21 |
| liver | 0/20 |
| lung | 6/75 |
| lymphocyte | 1/16 |
| ovary | 1/26 |
| pancreas | 1/24 |
| peripheral nervous system | 0/16 |
| plasma cell | 2/15 |
| prostate | 0/1 |
| skin | 1/24 |
| soft tissue | 0/9 |
| thyroid | 0/2 |
| upper aerodigestive | 0/22 |
| urinary tract | 3/29 |
| uterus | 0/5 |
Essentiality in NALM6
- Essentiality Rank: 20
- Expression level (log2 read counts): 7.15
Expression Distribution
ATIC Expression in NALM6 Cells: 7.15